Evidence map›Paper›PMID 33752242›Full record

ArticleCardiovascular research2022

Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cycling.

Senka Ljubojević-Holzer, Simon Kraler, Nataša Djalinac, Mahmoud Abdellatif, Julia Voglhuber, Julia Schipke, Marlene Schmidt, Katharina-Maria Kling, Greta Therese Franke, Viktoria Herbst and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Mitophagy in Hypertensive Cardiac Hypertrophy: Mechanisms and Therapeutic Implications.Journal of clinical hypertension (Greenwich, Conn.) · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. KnockdownFrontiers in pharmacology · 2024
    Article
  19. Article
  20. Hallmarks of cardiovascular ageing.Nature reviews. Cardiology · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

Senka Ljubojević-HolzerDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
Simon KralerDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.ORCID 0000-0002-8245-7287
Nataša DjalinacDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
Mahmoud AbdellatifDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.ORCID 0000-0002-5042-9054
Julia VoglhuberDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.ORCID 0000-0003-0102-7902
Julia SchipkeInstitute of Functional and Applied Anatomy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.ORCID 0000-0003-0022-6109
Marlene SchmidtDepartment of Translational Research, Comprehensive Heart Failure Center (CHFC), University Clinic Würzburg, Am Schwarzenberg 15, Haus A15, 97078 Würzburg, Germany.ORCID 0000-0003-1658-2175
Katharina-Maria KlingInstitute of Functional and Applied Anatomy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Greta Therese FrankeInstitute of Functional and Applied Anatomy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Viktoria HerbstDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
Andreas ZirlikDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.ORCID 0000-0001-6290-3297
Dirk von LewinskiDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.ORCID 0000-0001-9996-6128
Daniel ScherrDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
Peter P RainerDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.ORCID 0000-0002-2840-6454
Michael KohlhaasDepartment of Translational Research, Comprehensive Heart Failure Center (CHFC), University Clinic Würzburg, Am Schwarzenberg 15, Haus A15, 97078 Würzburg, Germany.ORCID 0000-0001-6132-6037
Alexander NickelDepartment of Translational Research, Comprehensive Heart Failure Center (CHFC), University Clinic Würzburg, Am Schwarzenberg 15, Haus A15, 97078 Würzburg, Germany.
Christian MühlfeldInstitute of Functional and Applied Anatomy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Christoph MaackDepartment of Translational Research, Comprehensive Heart Failure Center (CHFC), University Clinic Würzburg, Am Schwarzenberg 15, Haus A15, 97078 Würzburg, Germany.ORCID 0000-0003-3694-4559
Simon SedejDepartment of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.ORCID 0000-0002-4419-6821
Medical University of Graz · ATMedizinische Hochschule Hannover · DEUniversitätsklinikum Würzburg · DE

Funding

Austrian Science Fund FWF I 3301Austrian Science Fund FWF P 27637
6 · The paper itself

Abstract

aimsAutophagy protects against the development of cardiac hypertrophy and failure. While aberrant Ca2+ handling promotes myocardial remodelling and contributes to contractile dysfunction, the role of autophagy in maintaining Ca2+ homeostasis remains elusive. Here, we examined whether Atg5 deficiency-mediated autophagy promotes early changes in subcellular Ca2+ handling in ventricular cardiomyocytes, and whether those alterations associate with compromised cardiac reserve capacity, which commonly precedes the onset of heart failure. METHODS AND

resultsRT-qPCR and immunoblotting demonstrated reduced Atg5 gene and protein expression and decreased abundancy of autophagy markers in hypertrophied and failing human hearts. The function of ATG5 was examined using cardiomyocyte-specific Atg5-knockout mice (Atg5-/-). Before manifesting cardiac dysfunction, Atg5-/- mice showed compromised cardiac reserve in response to β-adrenergic stimulation. Consequently, effort intolerance and maximal oxygen consumption were reduced during treadmill-based exercise tolerance testing. Mechanistically, cellular imaging revealed that Atg5 deprivation did not alter spatial and functional organization of intracellular Ca2+ stores or affect Ca2+ cycling in response to slow pacing or upon acute isoprenaline administration. However, high-frequency stimulation exposed stunted amplitude of Ca2+ transients, augmented nucleoplasmic Ca2+ load, and increased CaMKII activity, especially in the nuclear region of hypertrophied Atg5-/- cardiomyocytes. These changes in Ca2+ cycling were recapitulated in hypertrophied human cardiomyocytes. Finally, ultrastructural analysis revealed accumulation of mitochondria with reduced volume and size distribution, meanwhile functional measurements showed impaired redox balance in Atg5-/- cardiomyocytes, implying energetic unsustainability due to overcompensation of single mitochondria, particularly under increased workload.

conclusionLoss of cardiac Atg5-dependent autophagy reduces mitochondrial abundance and causes subtle alterations in subcellular Ca2+ cycling upon increased workload in mice. Autophagy-related impairment of Ca2+ handling is progressively worsened by β-adrenergic signalling in ventricular cardiomyocytes, thereby leading to energetic exhaustion and compromised cardiac reserve.

Indexed as

CalciumMyocytes, CardiacAdrenergic AgentsAnimalsAutophagyAutophagy-Related Protein 5HumansMiceMice, KnockoutMitochondriaAdrenergic AgentsATG5 protein, humanAtg5 protein, mouseAutophagy-Related Protein 5CalciumAutophagyBeta-adrenergic signallingCalciumCardiomyocytesMitochondria

Identifiers

PMID33752242
PMCPMC9074988
OpenAlexW3137416191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.